Newfound Research’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$85K Sell
2,198
-353
-14% -$14.2K 0.21% 31
2022
Q2
$95K Buy
2,551
+919
+56% +$37.4K 0.2% 42
2022
Q1
$72K Buy
1,632
+53
+3% +$2.3K 0.09% 127
2021
Q4
$67K Buy
1,579
+273
+21% +$11.5K 0.08% 120
2021
Q3
$57K Buy
+1,306
New +$57.8K 0.09% 114

Other funds holding BSX

Newfound Research's BSX Position: Q3 2022 in Review

Newfound Research reduced its Boston Scientific (BSX) stake by 14% in Q3 2022, selling an estimated $14.2K and leaving 2,198 shares worth $85K. The position accounts for 0.21% of the portfolio, ranked #31.

Newfound Research first reported a position in BSX in Q3 2021 and has held it in 5 quarters since. The position peaked at $95K in Q2 2022. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Newfound Research held 2,198 shares of Boston Scientific worth $85K as of Q3 2022.
  • Newfound Research sold 353 Boston Scientific shares in Q3 2022, an estimated $14.2K.
  • Boston Scientific made up 0.21% of Newfound Research's portfolio in Q3 2022, its #31 holding.
  • Newfound Research first reported a position in Boston Scientific in Q3 2021 and has held it in 5 quarters since.
  • Newfound Research's Boston Scientific position peaked at $95K in Q2 2022.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.